Apogee Therapeutics, Inc. (APGE) Free Cash Flow
Apogee Therapeutics, Inc. (APGE) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2022-12-31 | -$16.43M |
| 2023-12-31 | -$74.93M |
| 2024-12-31 | -$172.33M |
| 2025-12-31 | -$232.65M |
How APGE compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| RCKT | Rocket Pharmaceuticals Inc. | -$190.45M |
| NKTR | Nektar Therapeutics | -$208.68M |
| OCUL | Ocular Therapeutix Inc. | -$216.89M |
| NVAX | Novavax Inc. | -$250.99M |
| ARVN | Arvinas Inc. | -$275.70M |
These are five companies in the same sector as APGE with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Apogee Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("APGE", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | APGE | $134.79 | +0.03% | 1.15M |
| 3 | ||||
| 4 | ||||
| 5 |